Viral co-infection with SARS-CoV-2 in hospitalized Peruvian patients during 2020-2021. [PDF]
Yabar CA +13 more
europepmc +1 more source
Viral Pathogens and Pulmonary Fibrosis: EMT-Driven Mechanisms and Insights From Traditional Chinese Medicine. [PDF]
Zang N +9 more
europepmc +1 more source
Design and in silico evaluation of an mRNA vaccine against HTLV-1 using AI-driven reverse vaccinology approaches. [PDF]
Seifi N +3 more
europepmc +1 more source
Immune escape mechanisms and therapeutic advances in virus-associated hematological malignancies. [PDF]
Li T +6 more
europepmc +1 more source
FC-duplex IgG1 (HTLV-1/2): Qualifying the flow cytometry IgG1 duplex assay for differential diagnosis of HTLV-1 and HTLV-2 infections. [PDF]
Martins JP +14 more
europepmc +1 more source
The HTLV-1 HBZ Oncoprotein and Its Role in Adult T-Cell Leukemia/Lymphoma. [PDF]
Accolla RS, Shallak M, Forlani G.
europepmc +1 more source
Therapeutic Approaches for HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis: Current and Emerging Strategies. [PDF]
Nakamura T, Satoh K.
europepmc +1 more source
Rapidly Progressive and Relapsing Myelitis With Human T Lymphotropic Virus Type 1: A Case Report and Review of the Literature. [PDF]
Morrison AA, Samudralwar RD, Berger JR.
europepmc +1 more source
Morbidity and Mortality Among People Living With HTLV-1: A 30-Year Retrospective Analysis in a Brazilian Cohort. [PDF]
Neves ES +10 more
europepmc +1 more source
HTLV-1 and Co-infections [PDF]
HTLV-1 is a retrovirus that causes lifelong T-cell infection in humans, impacting the host immune response. This virus causes a range of clinical manifestations, from inflammatory conditions, including neuronal damage (HTLV-1 associated myelopathy, HAM ...
Graham P Taylor, Carolina Rosadas
exaly +2 more sources

